1-3 of 3
Siyun He
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pomalidomide, rituximab, and orelabrutinib in combination with polatuzumab vedotin for newly diagnosed diffuse large B-cell lymphoma in elderly, unfit, or frail patients:a prospective phase II study

Free
Changju Qu, Nana Ping, Qian Zhu, Junhong Li, Xiao Zhang, Fan Xia, Rui Zou, Siyun He, Depei Wu, Zhengming Jin
Journal: Blood
Blood (2025) 146 (Supplement 1): 1912.
https://doi.org/10.1182/blood-2025-1912
Published: 2025
Journal Articles

Dual epigenetic modulation with obinutuzumab/liposomal mitoxantrone in refractory or Relapsed Diffuse large B-cell lymphoma patients post-salvage therapy: A phase II study

Free
Changju Qu, Nana Ping, Rui Zou, Jiajie He, Qian Zhu, Junhong Li, Xiao Zhang, Fan Xia, Danqing Kong, Siyun He, Depei Wu, Zhengming Jin
Journal: Blood
Blood (2025) 146 (Supplement 1): 5468.
https://doi.org/10.1182/blood-2025-5468
Published: 2025
Journal Articles

Chidamide in combination with brentuximab vedotin for CD30+ peripheral T-cell lymphoma in patients ineligible for chemotherapy: a prospective phase II study

Free
Changju Qu, Nana Ping, Danqing Kong, Qian Zhu, Junhong Li, Xiao Zhang, Fan Xia, Rui Zou, Siyun He, Depei Wu, Zhengming Jin
Journal: Blood
Blood (2025) 146 (Supplement 1): 7167.
https://doi.org/10.1182/blood-2025-7167
Published: 2025